Letter From The Editor

Jeremy Hodson Pettus, MD, and Steven Edelman, MD are back this week to help you understand adjunctive therapies that you can use with insulin patients to improve control of A1c’s, while improving weight loss success. Please check out part 2 of their discussion here. Insulin errors top the list when …

Sheri R. Colberg, PhD, FACSM has been writing for us for the past seven years and she is our go-to guru when it comes to anything that has to do with diabetes and physical activity. We are proud to announce that her new book, Exercise and Diabetes: A Clinician’s Guide …

This week in our Homerun Slides we get back to working with medications to focus on the core defects of diabetes and how selecting the right combinations can make a difference in the synergy and results, while our Disaster Averted looks at what happens when there are transcribing and order …

We are at a point with oral medications for diabetes where there are new drug approvals in recently approved classes, new drug classes where the first in class is approved, as well as late trial research moving quickly for drugs in yet unapproved classes. First it was the DPP-4 inhibitors with …

I just finished up a two day advisory board meeting for an insulin manufacturer. We looked at some new products and studies as well as new ideas about diabetes care. Part of our discussion had to do with the increased use of EMRs (electronic medical records), EHRs (electronic health records) and …

This week I happened to run into a physician friend I had not seen for a while. While we were chatting, I noticed that he must have gotten at least six pages from his answering service. Each time he had to call in and listen to the operator describe the …

Last month, in our first issue of these special edition newsletters we gave you the tools to become an expert on SGLT2-I therapy. In our second edition we want to help you dig deeper into this new class of drugs. To that end we have some great information for you. …

We often talk about the value of controlling lipids and glucose and their relation to patient health. If patients would only do what we tell them then the results would be good and our jobs would be easier. With the recent changes in healthcare, however, going through the motions of …

This past week we had our PharmD candidate, Lauren Self, scour the information from the AACE meeting in Phoenix, in order to prepare the best articles for you to review. The new AACE guidelines that Dr. Alan Garber delivered during the meeting focused on a tailored approach with increased use …

Have you ever heard of 1,5-Anhydroglucitol (1,5-AG)? If not get ready to learn in this week’s Homerun Slides why testing for this compound will give a more accurate scorecard on diabetes care than an A1c or finger stick could even come close to. Our Disaster Averted is an analysis of …